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Abstract
Exposures to diesel exhaust particles (DEP) from traffic and house dust mite (HDM) allergens significantly increase risks of airway
diseases, including asthma. This negative impact of DEP and HDM may in part be mediated by epigenetic mechanisms. Beyond
functioning as a mechanical barrier, airway epithelial cells provide the first line of immune defense towards DEP and HDM expo-
sures. To understand the epigenetic responses of airway epithelial cells to these exposures, we exposed human bronchial epi-
thelial cells to DEP and HDM and studied genome-wide 5-methyl-cytosine (5mC) and 5-hydroxy-methylcytosine (5hmC) at base
resolution. We found that exposures to DEP and HDM result in elevated TET1 and DNMT1 expression, associated with 5mC and
5hmC changes. Interestingly, over 20% of CpG sites are responsive to both exposures and changes in 5mC at these sites nega-
tively correlated with gene expression differences. These 5mC and 5hmC changes are located in genes and pathways related to
oxidative stress responses, epithelial function and immune cell responses and are enriched for binding sites of transcription fac-
tors (TFs) involved in these pathways. Histone marks associated with promoters, enhancers and actively transcribed gene bodies
were associated with exposure-induced DNA methylation changes. Collectively, our data suggest that exposures to DEP and
HDM alter 5mC and 5hmC levels at regulatory regions bound by TFs, which coordinate with histone marks to regulate gene net-
works of oxidative stress responses, epithelial function and immune cell responses. These observations provide novel insights
into the epigenetic mechanisms that mediate the epithelial responses to DEP and HDM in airways.
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Introduction
Exposure to house dust mite (HDM) allergen is common, and as
many as 50% of asthmatic patients are sensitized to HDM [1].
The causal role of HDM in allergic asthma is well established [2].
Importantly, allergic asthma phenotypes induced by HDM can
be exacerbated by exposures to traffic-related air pollution [3–6].
Traffic-related air pollutants are a complex mixture of gaseous
and particulate components with adverse effects on health sup-
ported by ample evidence [7–11]. Among traffic-related air pol-
lution, diesel exhaust particles (DEP) are of particular concern
with respect to health effects, due to their abundance and very
small sizes. It is estimated that DEPs contribute up to 90% of the
particulate matter (PM) derived from traffic sources. They are
primarily ultrafine in size (<100 nm), and can be deposited in
the nasal or peripheral airways. DEPs have been shown to in-
duce oxidative stress and enhance allergic responses and air-
way inflammation induced by HDM [3–6]. Globally, a significant
portion of all populations lives in regions with high traffic-
related air pollution, including schools [7, 12–14]. Therefore, it is
essential to understand how DEP exposure exacerbates HDM-
induced allergic asthma.
Accumulating evidence supports that epigenetic mecha-
nism(s) may explain the effects of DEP and HDM on airways and
asthma. Both DEP and HDM have been shown to modify DNA
methylation of the airways [15]. We recently demonstrated that
TET1 (Ten Eleven Translocation 1) promoter methylation is as-
sociated with childhood asthma and exposure to traffic-related
air pollution [16]. A member of the TET enzyme family (TET1/2/
3), TET1 converts 5mC to oxi-mCs including 5-hydroxymethyl-
cytosine (5hmC), 5-formylcytosine (5fC) and 5-carboxylcytosine
(5caC), ultimately resulting in DNA demethylation. In contrast,
the de novo addition of DNA methylation is achieved by DNA
methyl-transferases 3 A and 3B (DNMT3A and 3B), while DNMT1
is responsible for 5mC addition during DNA replication. Among
these cytosine modifications, 5hmC is often found at
enhancers, with a direct role for 5hmC in demethylation of
enhancers during development and gene activation [17–24]. In
addition, similar to 5mC, 5hmC is also enriched in promoters
and gene bodies and functions as a stable marker for setting up
the epigenetic landscape through interactions with other pro-
teins [17–19, 25–27] and functions in both transcriptional activa-
tion and repression [28]. TET1 has been shown to be regulated
by DEP exposure in human bronchial epithelial cells [16]. TET1
expression is also regulated by HDM exposure in mouse lungs,
while TET2 and TET3 remain unchanged [29]. In the same mouse
model, the expression of DNMT3A was significantly decreased,
while DNMT1 and DNMT3B remained unchanged. To date, it
remains unclear how the dysregulation of TET1 by exposures
alters 5mC and 5hmC in airway epithelial cells. This is likely
due to the difficulty of measuring 5mC and 5hmC individually.
In this paper, we studied the genome-wide 5mC and 5hmC
response to DEP and HDM by combining BiSulfite (BS) and oxi-
dative BiSulfite (oxBS) conversion at base resolution. We exam-
ined the relationships among locations with differential 5mC
and 5hmC in response to different exposures. In order to under-
stand the functional relevance of identified changes, we per-
formed transcriptomic analysis, gene ontology and pathway
analysis, and functional genomics to examine TF binding and
histone marks. To our knowledge, this is the first study to ex-
amine the impact of DEP and HDM exposures on 5mC and
5hmC at base-resolution on a genome-wide scale in airway epi-
thelial cells.
Results
Exposure to Diesel Exhaust Particles and House Dust
Mite Significantly Alters the Expression of TET1, DNMT1
and DNMT3A in Airway Epithelial Cells
Previously we have shown in nasal epithelial cells that TET1
promoter methylation is associated with childhood asthma and
traffic related air pollution [30]. To further understand the regu-
lation of TET1/2/3 by DEP (major particulate matter in traffic-
related air pollution) and HDM (an allergen known to increase
asthma risk), we examined whether exposure to HDM or DEP
alters the expression levels of TET1/2/3 (Fig. 1A). Consistent with
our previous observations [16], in presence of 5lg/cm2 DEP, the
expression of TET1 significantly increased at 1 h and returned to
baseline at 4 h (Fig. 1B). We observed similar time-specific pat-
terns when exposing HBECs with 25 lg/ml of HDM (Fig. 1C). No
significant cell death was observed under these conditions [16].
As TET2 and TET3 are enzymes that have similar functions to
TET1, we also assessed the expression of TET2 and TET3. In
contrast to TET1, the expression of TET2 and TET3 did not
significantly change following DEP and HDM challenge
(Supplementary Fig. S1). DNMT1 showed significant upregula-
tion at 24 hrs following either DEP or HDM exposure (Fig. 1B and
C). Meanwhile, the expression of DNMT3A, a de novo DNA meth-
ylase, was significantly upregulated at 4 h by DEP (Fig. 1B and C),
while the expression of DNMT3B trended higher at 4 h
(Supplementary Fig. S1). In contrast HDM exposure significantly
downregulated DNMT3B at 24 h (Supplementary Fig. S1). In con-
clusion, exposures to DEP and HDM regulate the expression of
enzymes involved in DNA methylation maintenance in a se-
quential manner.
Exposures to DEP and HDM Altered 5mC and 5hmC in
Airway Epithelial Cells
As TET1, DNMT3A and DNMT1 are involved in the DNA demeth-
ylation and methylation processes, we next assessed genome-
wide 5mC and 5hmC levels by assaying DNA from bisulfite
treatment (BS) and oxidative bisulfite treatment (oxBS) with
Illumina MethylationEPIC chips [31, 32]. Of note, BS measures
the sum of 5mC and 5hmC, while oxBS measures 5mC only. The
levels of 5hmC can thus be derived as the difference between BS
signal and oxBS signal. EPIC arrays interrogate 8 63 904 CpG
sites, which covers CpG islands, non-CpG sites, cancer and
reprogramming related differentially methylated CpG sites,
FANTOM5 enhancers, ENCODE open chromatin, ENCODE tran-
scription factor binding sites and miRNA promoter regions.
Following 24 h exposures to 5 lg/cm2 DEP, 5200, 16 154 and
19 074 CpG sites underwent changes (Difference 0.10) in
5mCþ 5hmC, 5mC and 5hmC, respectively (Fig. 2;
Supplementary Table S3A, B and C). Among these, 87 sites had
changes in 5mCþ 5hmC, 5mC and 5hmC. Interestingly, there
are 7351 sites with changes in both 5mC and 5hmC, but not in
5mCþ 5hmC, due to opposite directions of change in 5mC and
5hmC (Fig. 2A). Overall, 68.6% of all sites with 5mC changes
showed decreased levels and 72.7% sites of all sites with 5hmC
changes showed increased levels of 5hmC following DEP expo-
sure. In response to a 24 h stimulation with 25 lg/ml of HDM,
similar patterns were observed for 5mCþ 5hmC, 5mC and
5hmC (Fig. 2B and Supplementary Table S3D, E and F). These
observations are consistent with the significant up-regulation
of TET1, DNMT3A and DNMT1 following DEP exposure and
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similar changes of TET1 and DNMT1 following HDM exposure.
Processes that possibly occur may include active conversion of
5mC to 5hmC by TET1, de novo methylation by DNMT3A and
maintenance of only 5mC marks by DNMT1 through DNA repli-
cation that results in retention of 5mC marks and removal of
5hmC marks (passive demethylation).
Exposures to DEP and HDM Induced Changes at
Genomic Locations near Genes Involved in Oxidative
Stress Responses, Epithelial Function and Immune Cell
Responses
As co-exposure to DEP and HDM is associated with increased
wheezing and asthma risk [5], we hypothesized that DEP and
HDM exposures modify common genes and pathways through
epigenetic mechanisms. For total DNA methylation levels
(5mCþ 5hmC), 5mC and 5hmC, respectively, 975, 2999 and 4221
sites were found that responded to both DEP and HDM (Fig. 3A;
Supplementary Table S4A, B and C). Among 1960 CpG sites with
changes in 5mC but not in 5hmC, 41% showed reduced 5mC
level in both exposures; among the 3182 CpG sites with changes
in 5hmC only, 45% of them showed increased 5hmC levels;
among the 1039 CpG sites that showed changes in both 5mC
and 5hmC, 1035 showed opposite directions of changes in 5mC
and 5hmC and 26% of them showed reduced 5mC and increased
5hmC (Fig. 3A). Sites in S2 represent CpG sites with increase in
5hmC, while sites in S8 include those that have decreased
5hmC, both S2 and S8 have no changes in 5mC (Fig. 3B). Sites lo-
cated in S4 are those with increased 5mC and sites in S6 repre-
sent CpG sites with decreased 5mC, both have no changes in
5hmC. Sites in S3 are those with decrease in 5mC and simulta-
neous increase in 5hmC (5mC loss/5hmC gain), while sites in S7
represent CpG sites with increase in 5mC and decrease in 5hmC
(5mC gain/5hmC loss). These different combinations of changes
in 5mC, 5hmC and 5mCþ 5hmC suggest distinct underlying
mechanisms resulting in such changes. Compared to the distri-
bution of all CpG sites included on the EPIC arrays, fewer CpG
sites whose 5hmC levels are responsive to DEP and HDM are lo-
cated at CpG islands (11% vs. array 20%, p< 0.001) and pro-
moters (defined as TSS200þTSS1500, 14% vs 20%, p< 0.001),
more are located at open seas (64% vs. array 55%, p< 0.001)
(Supplementary Fig. S2A), intergenic regions (29% vs. 32%,
p< 0.001) and gene body (43% vs. 37%, p< 0.001)
(Supplementary Fig. S2B). This is consistent with the notion
that 5hmC is enriched at gene bodies and enhancers [33, 34].
Further, we examined the correlation between changes in
5mCþ 5hmC, 5mC and 5hmC with changes in gene expression,
and observed negative correlation between expression and
changes in 5mC (Fig. 3C).
Among genes close to sites that were responsive to both DEP
and HDM and had changes in 5mCþ 5hmC, IPA analysis defined
31 enriched pathways (Supplementary Table S5A). There were
173 significantly enriched pathways among genes with changes
in 5mC (out of 405 enriched pathways in total), and 213
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Fig. 1: time-specific responses of TET1 and DNMT expression to DEP and HDM exposures in HBECs. (A) Experimental design. HBECs were exposed to Phosphate-buff-
ered saline (PBS), DEP (5 lg/cm2) or HDM (25 lg/ml). Expression of TET1, DNMT1 and DNMT3A was measured by RT-qPCR. (B) and (C) Expression values (normalized to
GADPH) were further normalized to the mean of controls at the indicated time points. Mean values from four biological replicates are represented as the mean 6 SD.
Treated group were compared to controls using a two-sided Student’s t test. *P<0.05, **P<0.01, ***P<0.001, n.s. represents not significant.
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significantly enriched pathways (400 enriched pathways in to-
tal) for genes with 5hmC changes (Supplementary Table S5B
and C). The relationships between these pathways are shown
in Fig. 4, with the most pathways identified from genes with
opposite changes in 5mC and 5hmC. Several pathways known
to be activated in response to DEP and HDM are highlighted,
such as NRF2-mediated Oxidative Stress Response, Epithelial
Adherence Junction Signaling, EGF signaling, NF-jB Signaling,
and T helper cell differentiation and activation (Th1/Th2/Th17).
In conclusion, our genome-wide analyses showed that DEP and
HDM exposures epigenetically regulate the same pathways by
altering the levels of 5mC and 5hmC and leading to changes in
gene expression.
Genes with 5mC and 5hmC Levels Responsive to DEP
and HDM Are Regulated by TET1
We chose 3 CpG sites located within the CMTM1, DNAH10 and
CNTF genes with three different patterns of change and verified
these changes using pyrosequencing in the same samples mea-
sured by arrays (Supplementary Fig. S3). These three sites were
chosen based on their effect size in 5mCþ 5hmC, 5mC or 5hmC
(10%), representative patterns in 5mC and 5hmC changes, and
biological relevance. CMTM1 belongs to the chemokine-like fac-
tor superfamily, links chemokines with the transmembrane 4
superfamily [35], and is widely expressed in lung tissues.
DNAH10 (encoding dynein axonemal heavy chain) is expressed
in cilia and flagella, and is the force-generating protein of
Fig. 2: exposures to DEP and HDM alter 5mCþ5hmC, 5mC and 5hmC in HBECs. (A) Venn diagram showing the degree of overlap between sites with 5mCþ5hmC, 5mC
and 5hmC changes in response to 24h treatment of 5 lg/cm2 DEP. The table lists number of CpG sites with different directions of changes in 5mC and 5hmC. (B) Venn
diagram for 5mCþ5hmC, 5mC and 5hmC changes in response to 24h treatment of 25 lg/ml HDM. The table lists number of CpG sites with different directions of
changes in 5mC and 5hmC.
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respiratory cilia. CNTF (ciliary neurotrophic factor) is an IL6-
type family cytokine released by airway smooth muscle cells in
response to stimuli [36]. It enhances IgE production by B cells
from atopic patients [37] and is upstream of STAT3 signaling to
promote survival and/or differentiation in many cell types [38].
The CpG sites located within CMTM1 and DNAH10 showed a de-
crease in 5mCþ 5hmC, no change in 5mC, and a decrease in
5hmC. In contrast, the CpG site located within CNTF showed no
difference in 5mCþ 5hmC, a decrease in 5mC and an increase in
5hmC.
We then tested whether different doses of DEP and HDM
would cause similar changes in 5mC and 5hmC and found that
higher doses of exposures (20 lg/cm2 for DEP and 100 lg/ml for
HDM) did not further dysregulate 5mCþ 5hmC, 5mC and 5hmC
(Supplementary Fig. S4). Similar results were found for co-
exposure to DEP and HDM for these two sites (data not shown).
As predicted from previous studies showing that 5mC and
5hmC levels are associated with gene regulation [39–41], the ex-
pression levels of CMTM1 and CNTF were significantly increased
24 h after DEP exposure (Fig. 5A and B, did not measure DNAH10
due to technical difficulties). To further establish the direct
involvement of TET1 in the regulation of these genes, TET1 was
knocked down by over 70% using siRNAs (Fig. 5C), and the
expression of CMTM1 and CNTF were significantly increased
in HBECs (Fig. 5D and E). Along with the increase in gene
expression, there was significant reduction of total DNAm
(5mCþ 5hmC) at CMTM1 promoter (Fig. 5F). Combined with data
shown in Fig. 3C, our data support the regulation of gene ex-
pression by TET1 and DNAm changes following exposures.
5mC and 5hmC Changes Shared by DEP and HDM
Challenges Are Located at TF Binding Sites and
Co-Localize with Histone Marks for Promoters
and Enhancers
To understand the possible functions of the DNAm variations
(5mC or 5hmC) shared by DEP and HDM, we performed compre-
hensive bioinformatic searches for possible TF binding around
these sites. Two approaches were taken. First, we searched for
enriched TF ChIP-seq peaks around these sites (see Methods)
and found 273 and 409 datasets whose binding sites signifi-
cantly overlap with exposure-induced 5hmC and 5mC changes,
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Fig. 3: common CpG sites are responsive to DEP and HDM challenges, and 5mC changes at these sites are correlated with gene expression differences. (A) Venn
Diagram showing the relationship of sites with 5mCþ5hmC, 5mC and 5hmC changes common to DEP and HDM. (B) Number of CpG sites with different directions of
changes in 5mC and 5hmC. (C) Correlation between changes in gene expression and DNAm after DEP and HDM treatment. Only CpG sites responsive to both treat-
ments were examined, with squares and triangles representing sites responsive to DEP and HDM, respectively. Sites in red were within the regulatory regions
(TSS1500, TSS200, 5’UTR and 1stExon). Trend of correlation was indicated by the red lines. n: number of observations; r: Spearman’s correlation coefficient; P value test-
ing if r is different from 0.
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respectively (corrected P-value < 106) (Supplementary
Table S6, top TFs shown in Fig. 6A and B). The large number of
significant sites is perhaps not unexpected, given that 5hmC
and 5mC-marked regions of the genome are often found in gene
promoters. Additionally, different TFs seem to be enriched for
regions with different directions of changes in 5mC, 5hmC and
5hmCþ 5hmC (Fig. 6C–H). Among the top TFs associated with
5hmC changes (Fig. 6A), NRF2 (GABPA) is a known key player in-
volved in oxidative stress response and detoxification processes
[42] and asthma development [43, 44]. This TF was also associ-
ated with regions with exposure-induced 5mC changes (Fig. 6B
and E–H), with the only exception of regions with increased
5hmC and no 5mC changes (6C). Besides NR2F2, there was an
enrichment for NFKB1 binding in A549 cells around sites with
overall 5mC changes (Fig. 6B and Supplementary Table S6B) and
sites with 5mC loss/no 5hmC changes (Fig. 6F). NFKB1 is a subu-
nit of NF-jB complex that is downstream of oxidative stress
produced by exposures to HDM and DEP in airway epithelial
cells [11, 45, 46]. In addition, there was enrichment for several
TFs that either directly modify chromatin or interact with chro-
matin modifiers to regulate gene expression, such as EP300 [47],
YY1 [48], MAX/MYC [49], HINFP [50, 51], CTCF [52–55], EHZ2 [56]
and SIN3A [57]. Among these, EZH2 is part of the Polycomb re-
pressive complexes 2/3 (PRC2/3, EZH2/SUZ12/EED) and is known
to interact with Tet1 [58]. EZH2 was enriched in regions with
5hmC and/or 5mC changes (6B–6H) and SUZ12 was also found
enriched in our dataset (Supplementary Table S6A). SIN3A, an-
other known TET1 binding partner [59], was significantly
enriched at regions with 5hmC loss and no 5mC changes
(Fig. 6H). This supports a possible interaction between SIN3A,
TET1 and local 5hmC marks. Importantly, EZH2 and SIN3A were
found in lung-related cell lines including bronchial epithelial
cells (A549) and lung fibroblasts (NHLF) (Fig. 6 and
Supplementary Table S6A).
As a second approach to identify relevant TFs, we performed
searches for enriched TF binding motifs within regions display-
ing 5mC and/or 5hmC changes in response to DEP and HDM in
airway epithelial cells (top TFs shown in Fig. 7A and B).
Similarly, different TFs seem to be enriched for regions with dif-
ferent directions of changes in 5mC, 5hmC and 5hmCþ 5hmC
(Fig. 7C–H). Consistent with the ChIP-seq analysis, motifs for
MYC/MAX and NR2F2 are strongly enriched in regions with
changes in 5hmC and 5mC status (Fig. 7A and B). Another top
TF enriched at regions with 5hmC/5mC changes, STAT3, is
known to be involved in epithelial responses to DEP [60] and LPS
[61], activation of EGF signaling [62], T helper cell differentiation
[63] and asthma [64]. It is specifically enriched at regions with
5mC gain/no 5hmC change (Fig. 7E) and regions with 5mC gain/
5hmC loss (Fig. 7G). The roles of vitamin D and its receptor VDR
in allergic disorders including asthma have also been widely
studied [65–67]. Enrichment for VDR binding was found in
regions with 5hmC gain/no 5mC changes (Fig. 7C) and regions
with 5mC gain/no 5hmC changes (Fig. 7E).
In addition to the study of TFs, our analysis also showed that
genomic sites with 5hmC/5mC changes in response to HDM in
HBEC have significant enrichment of both active histone marks
(H3K4me3, H3K4me1, H3K36me3, H3K27ac, etc.) and repressive
histone marks (H3K27me3, H3K9me3, H2AZ, etc.) that are
Fig. 4: exposures to DEP and HDM modify 5mC and 5hmC levels of genes in relevant pathways. IPA analyses were performed for genes with 5mCþ5hmC, 5mC and
5hmC changes, respectively. The Venn diagram shows the relationship between significantly enriched pathways from the three datasets. Pathways known to be in-
volved in DEP and HDM responses are indicated.
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associated with promoters and enhancer (Fig. 8A and B).
Specifically, all of these active and repressive markers were
found around CpG sites associated with 5hmC changes (Fig. 8C,
D, G and H). This is consistent with previous observations
that TET1 and 5hmC are associated with active “H3K4me3 only”
promoters, bivalent poised “H3K4me3/H3K27me3” promoters,
repressed “H3K27me3” promoters, “H3K4me1” enhancers,
H3K36me3 marked gene bodies and CTCF marked insulators
[27, 28, 68]. The same histone marks were also significantly
enriched around sites with changes in both 5mC and
5hmC (Fig. 8D and G) and sites with changes in 5mC only
(Fig. 8E and F). Collectively, our data suggest that 5mC and
5hmC differences induced by DEP and HDM may alter the bind-
ing of particular TFs and histone modifiers, which can in turn
alter promoter/enhancer activity and regulate gene expression
networks in airway epithelial cells.
Discussion
In this paper, we studied the effects of DEP and HDM exposures
on the expression of TET and DNA methylation on a genome-
wide scale in airway epithelial cells (HBECs). We used a cutting-
edge technology (oxidative bisulfite conversion) that allowed us
to assess 5mC and 5hmC not only together (5mCþ 5hmC) but
also individually. We found that following DEP and HDM chal-
lenge in HBEC cells, there is a significant early increase in TET1
expression, and there are genome-wide changes in
5mCþ 5hmC, 5mC and 5hmC modifications. Some of these
changes are common to both exposures, and many of them
occur at genes and pathways associated with oxidative stress
responses, epithelial function, and immune cell responses. In
general, changes in gene expression were correlated negatively
with changes in 5mC, but not 5mCþ 5hmC or 5hmC. For CMTM1
and CNTF, changes in 5mC and 5hmC are associated with gene
expression differences and TET1 regulates their expression
through modification of DNAm. Importantly, 5mC and 5hmC
changes that are common to DEP and HDM exposures occur at
binding sites for histone modifiers, as well as TFs involved in
oxidative stress responses, epithelial function and immune cell
responses. These DEP/HDM induced 5mC and 5hmC changes
are associated with histone marks representative of promoters
and enhancers. Taken together, our data suggest a novel regula-
tion of gene networks in oxidative stress responses, epithelial
function, and immune cell responses by TET1, 5mC and 5hmC
following DEP and HDM challenges in airway epithelial cells.
We chose to treat airway epithelial cells using 5 lg/cm2 DEP
and 25 lg/ml HDM because these doses upregulate the expres-
sion of TET1 without causing toxicity in airway epithelial cells.
It has also been shown that these two treatments induced sig-
nificant downstream aryl hydrocarbon receptor signaling, oxi-
dative stress and proinflammatory responses and were used to
examine the effects of real exposures [16, 69]. From candidates
identified with the genome-wide array analysis, we verified
three CpG sites using BS and oxBS pyrosequencing in the same
DNA samples and then replicated our findings using a dose re-
sponse design (Supplementary Figs S3 and S4). We correlated
gene expression measured by RNA-seq with changes in
5mCþ 5hmC, 5mC and 5hmC, and found a statistically
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Fig. 5: regulation of CMTM1 and CNTF expression by exposures and TET1. HBECs were treated with 5 lg/cm2 DEP and expression levels of CMTM1 (A) and CNTF (B) were
measured and normalized as described in Fig. 1. Mean values from three biological replicates are represented as the mean 6 SD. The expression levels of TET1, CMTM1
and CNTF after TET1 siRNA knockdown are shown in C, D and E. F. Methylation of cg04791678 in CMTM1 after siRNA #1 knockdown of TET1. Mean values from six bio-
logical replicates are represented as the mean 6 SD. Groups were compared using a two-sided Student’s t test. *P<0.05, **P<0.01, ***P<0.001, n.s. represents not
significant.
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significant negative correlation between changes in 5mC and
gene expression (Fig. 3C). However, the two candidate CpG sites
(cg26411814 and cg04791678) showed different patterns of asso-
ciations between 5mCþ 5hmC, 5mC and 5hmC with gene acti-
vation (CNTF and CMTM1, respectively) in response to DEP
(Supplementary Figs S3 and S4, Fig. 5A and B) and TET1 knock
down (Fig. 5D–F). This indicates that the regulation of gene ex-
pression by 5mC and 5hmC is both locus-specific and exposure-
specific, thus highlights the importance of studying 5mC and
5hmC individually. Therefore, we recommend cautious inter-
pretation of negative results in correlation studies between
DNAm (5mC and 5hmC) and gene expression in samples col-
lected at a certain time point.
Additionally, since TET2 and TET3 also regulate levels of
5hmC in terminally differentiated cells such as B and T cells [33,
70, 71], we measured their expression levels and observed no
significant changes in TET2 and TET3 in response to DEP
(Supplementary Fig. S1). Following the upregulation of TET1, we
observed increased expression in DNMT1 and DNMT3A, consis-
tent with the different patterns of 5mC and 5hmC changes we
observed (Fig. 3B) and suggesting these 5mC and 5hmC changes
may be a result of dysregulation in both TET1 and DNMTs. We
speculate that regions with gain or loss in 5mC and no 5hmC
changes (S4 and S6 in Fig. 3B table) are regulated by DNMTs,
while regions with gain or loss in 5hmC and no 5mC changes
(S2 and S8) as well as regions with 5mC loss and 5hmC gain (S3)
are targeted by TET1. For regions with gain in 5mC and loss in
5hmC (S7), both enzymes are involved. Specifically, the changes
in 5hmC in all scenarios may be either due to a redistribution of
TET1 binding across genome, or result from a complex regula-
tion of 5hmC by TET1 transcriptional upregulation and inhibi-
tion of TET1 enzymatic activity by oxidative stress produced by
HDM/DEP [27]. The enrichment of different TFs and co-
localization of both active and repressive histone marks is con-
sistent with a dual role of TET1 and 5hmC in gene regulation
[28, 68], which sometimes depends on the interacting partners
of TET1 besides 5hmC levels [27]. For example, TET1 interacts
with OGT and SET1/COMPASS complex to set up H3K4me3 and
activate gene transcription; it can also interact with SIN3A/
HDAC1, EZH2/SUZ12 and NURD complex to remove histone
acetylation, set up H3K27me3 and silence gene expression. To
support this, binding of SIN3A and EZH2/SUZ12 are enriched
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Fig. 6: potential TF binding at regions with 5hmC and 5mC changes following DEP and HDM exposures. We estimated the significance of the degree of overlap between
genomic regions with exposure induced 5hmC and/or 5mC changes and each member of a large library of transcription factor, co-factor, and other protein ChIP-seq
datasets (see Methods). The top 30 significant results are shown regardless of cell type, along with results from lung related datasets passing a P<106 significant
threshold. The X-axis indicates the protein, in decreasing order of significance. The Y-axis indicates the significance (–log P-value) of the overlap of the given ChIP-seq
dataset. The size of each box indicates the fold-enrichment relative to background (see Methods). The color of each box indicates the cell type: lung-related cell types
are shown in multi-color, and non-lung cell types are shown in dark blue (see key below). (A) all locations with exposure-induced 5hmC changes; (B) all locations with
exposure-induced 5mC changes; (C) 5hmC gain, 5mC no change; (D) 5mC loss, 5hmC gain; (E) 5mC gain, 5hmC no change; (F) 5mC loss, 5hmC no change; (G) 5mC gain,
5hmC loss; (H) 5hmC loss, no changes in 5mC. Detailed classification of 5mC and 5hmC changes are shown in Fig. 3B.
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among the sites with 5mC/5hmC changes (Fig. 6 and
Supplementary Table S6). However, not all sites interact with
the same TFs. Further experiments are needed to determine
whether TET1 directly bind to these loci in response to expo-
sures and how they regulate local 5mC/5hmC levels, chromatin
state, TF binding, and gene expression in a locus- and time-
specific manner.
To assess the 5hmC levels, we used the oxidative bisulfite
treatment, which involves harsh oxidation and reaction with
sodium bisulfite. DNA methylation arrays also exhibited vari-
ability in measurement. All these introduce noises to the esti-
mated beta value. One consequence is negative values when
estimating 5hmC by subtracting oxBS signal from the BS signal.
Though direct measurement of 5hmC by TAB-seq is possible
[26], this technology is associated with incomplete oxidation by
purified Tet1 protein (80–90%), making it harder to observe
small differences. To solve the problem, we applied mathemati-
cal strategies with a recent methodology named OxyBS [72]. To
account for the biological and experimental variability, we per-
formed technical duplicate experiments using pooled biologic
replicates as input and analysed the mean beta values. To en-
hance the potential of novel findings given the small sample
size, instead of a strict P value cutoff, we used difference of beta
values to indicate differential DNAm. We selected three biologi-
cally relevant CpG candidates. Out of 18 comparisons for these
three sites, only one showed uncorrected P value 0.05 when
array data were examined, while all of them were verified and
replicated, suggesting the usefulness of this cost-efficient
strategy.
In conclusion, using a cutting-edge technology and compre-
hensive bioinformatics analyses, our study identified novel
5mC and 5hmC changes following DEP and HDM challenges in
human bronchial epithelial cells and presented plausible evi-
dence supporting that these changes modify genes in oxidative
stress responses, epithelial function and immune cell responses
in coordination with specific transcription factors and histone
modifications. As oxidative stress responses, epithelial function
and immune cell responses are known important players in
asthma pathogenesis, our results suggest novel epigenetic
mechanisms contributing to asthma. Furthermore, a significant
portion of 5mC and 5hmC changes are shared by DEP and HDM,
which may mediate the interplay between these two exposures
in asthma development and exacerbation [5, 6].
Methods
Cell Culture and Treatment
Human bronchial epithelial cells (HBECs) (a cell line obtained
from Dr. John Minna’s lab at UT Southwestern Medical Center
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Fig. 7: transcription factor binding motif enrichment in regions with exposure-induced 5hmC and/or 5mC changes. Enrichment of transcription factor binding motifs
in genomic regions with 5hmC and/or 5mC changes following exposures. Enrichment was calculated using the HOMER software package and the Cis-BP motif library
(see Methods). The top 30 significantly enriched binding motifs are grouped by their corresponding transcription factors. The Y-axis indicates the significance (–log
P-value) of the enrichment of the given motif. The X-axis indicates the corresponding TF, in decreasing order of significance. Box size indicates the fold-enrichment
over background (see key below). (A) all locations with exposure-induced 5hmC changes; (B) all locations with exposure-induced 5mC changes; (C) 5hmC gain, 5mC no
change; (D) 5mC loss, 5hmC gain; (E) 5mC gain, 5hmC no change; (F) 5mC loss, 5hmC no change; (G) 5mC gain, 5hmC loss; (H) 5hmC loss, no changes in 5mC.
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[73]) were grown to 70% confluence in Keratinocyte-SFM se-
rum-free medium (10724-011, Life Technologies, Grand Island,
NY) supplemented with human recombinant Epidermal Growth
Factor (10450-013, Life Technologies, Grand Island, NY) and
Bovine Pituitary Extract (13028-014, Life Technologies, Grand
Island, NY). House dust mite extract (Dermatophagoides pteronys-
sinus) was purchased from Greer Laboratories (XPB70D3A2.5,
Lenoir, NC). DEP was generated from a 4-cylinder Deutz diesel
engine at the EPA (Research Triangle Park, NC); detailed charac-
terization of this compressor DEP has been described previously
and compared to other sources of DEP [74]. HBECs were cultured
to 70% confluency in a 12 well plate and starved overnight
(8 h), exposed to Saline, DEP (5 lg/cm2) or HDM (25 lg/ml) for
1–24 h in triplicate before harvest. For TET1 knockdown, cells
were treated with two TET1 siRNA (#1: sc-90457 from Santa Cruz
Biotechnology, Dallas, Texas; #2: AM16708 from Ambion,
ThermoFisher Scientific, Waltham, MA). TET1 knockdown was
performed according to the RNAiMAX protocol (ThermoFisher
Scientific). 1ul Lipofectamine RNAiMAX transfection reagent
(13778150, ThermoFisher) was added to 25ul Opti-MEM transfec-
tion medium (31985062, ThermoFisher). 1 lg TET1 siRNA from
Santa Cruz Biotechnology or 30 pmole TET1 siRNA from
Ambion, and their corresponding control scrambled siRNAs
were added to 25ul Opti-MEM transfection medium. The DNA
and lipid complex were then mixed together and incubated for
5 min. The DNA-Lipid complex was added to one well of a 12
well plate and cells were harvested 48 h later. DNA/RNA extrac-
tion from HBECs was performed using AllPrep DNA/RNA mini
kit (80294, Qiagen, Hilden, Germany) according to the manufac-
turer’s protocols.
Sample Processing and methylationEPIC Beadchip Array
Genomic DNA from each treatment in triplicates was isolated
and pooled. 1 lg DNA was then treated in duplicates with or
without oxidation using the TrueMethylVR protocol for array
analysis (NuGen) as follows: DNA was subjected to an initial
buffer exchange step using a beads-based approach included in
the kit and eluted in ultra-pure water. The full eluate (50ll per
sample) was carried forward. Samples were denatured using
the provided denaturing solution for 30 min at 37C, in a total
reaction volume of 50 ll and immediately taken forward to oxi-
dation. One ll of the provided oxidant solution was added to
each sample undergoing the oxBS workflow only (1 ll of ultra-
pure water was added to BS-only samples for mock oxidation).
All samples were incubated for 30 min at 40C. Oxidized sam-
ples were equilibrated to room temperature before proceeding
immediately to bisulfite conversion. Bisulfite reagent solution
A
C D E
F G H
B
P P
P P P
P P P
Fig. 8: overlap significance between 5mC or 5hmC-marked regions and histone marks. The significance of the degree of overlap between genomic regions with expo-
sure induced 5mC/5hmC changes and each member of a large library of histone mark ChIP-seq datasets was estimated (see Methods). Histone marks with at least one
significant result (P<102) are shown. The Y-axis indicates the histone mark, in decreasing order of significance. The X-axis indicates the significance (–log P-value) of
the overlap of the given dataset. The size of each circle indicates the fold-enrichment relative to background (see Methods). (A) all locations with exposure-induced
5hmC changes; (B) all locations with exposure-induced 5mC changes; (C) 5hmC gain, 5mC no change; (D) 5mC loss, 5hmC gain; (E) 5mC gain, 5hmC no change; (F) 5mC
loss, 5hmC no change; (G) 5mC gain, 5hmC loss; (H) 5hmC loss, no changes in 5mC.
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was prepared as described in the TrueMethylVR protocol and
170 ll was added to each 25 ll oxidation reaction mixture.
Finally, 5 ll of bisulfite additive was added to each reaction,
bringing the total volume to 200 ll. All reactions were incubated
using bisulfite-specific thermal cycling conditions. Converted
DNAs were purified using the provided spin columns and 4 ll of
each sample eluate was used as input into the Infinium EPIC ar-
ray. All spike-in and controls in TrueMethylVR Array Kit were in-
cluded to ensure the data quality and and the expected results
were obtained.
Array Processing
Array quality was assessed using sample-independent and de-
pendent internal control probes included on the array. All sam-
ples had >95% sites detected at P¼ 0.05 level; no quality issue
was observed in staining, extension, hybridization, specificity
or bisulfite conversion; therefore, samples were all included in
the analysis. The signal intensities were then background-
corrected using out-of-band probes (noob), and normalized us-
ing subset-quantile within array normalization (swan) with the
R package “minfi”. CpG sites that were not detected in all sam-
ples at P¼ 0.01 level, and CpG sites on the X and Y chromo-
somes were excluded.
Methylation levels were measured as b values
(b ¼ signalmethylationsignalmethylation þ signalunmethylation), and used in analyses. For each of
the samples, DNA without and with oxidation were assayed,
which directly measured the sum of 5mC and 5hmC (btotal), and
the 5mC levels (bmC). The levels of 5hmC (bhmC) were estimated
from BS and oxBS signals using the R package OxyBS [72].
Samples were assayed as technical duplicates; the average btotal,
bmC and bhmC were calculated and compared between control,
DEP and HDM treated sample. An absolute difference of 0.1 or
larger in b values was considered significant, which is consis-
tent with previous publications [16, 30, 75].
RNA-Seq Library Preparation, Sequencing and Analysis
Cells were harvested and RNA were isolated using the RNeasy
Mini Kit (Qiagen, Valencia, CA) following the manufacturer’s in-
struction. The concentration and integrity of the isolated RNA
was quantified using the Nanodrop 1000 (Thermo Fisher
Scientific, Wilmington, DE) and 2100 Bioanalyzer (Agilent, Santa
Clara, CA). A total of 1 lg RNA for each sample with RNA integ-
rity number (RIN) values >8 was used for sequencing library
construction. Briefly, polyA RNA was first purified via NEBNext
Poly(A) mRNA Magnetic Isolation Module (New England
BioLabs, Ipswich, MA). Using the polyA RNA as input, the library
for RNA-seq was prepared by using NEBNext Ultra Directional
RNA Library Prep kit. The approach uses dUTP-based method to
preserve strand information. After indexing via PCR (11 cycles)
enrichment, the amplified libraries together with library prepa-
ration negative control were cleaned up by AMPure XP beads
(Beckman Coulter, Brea, CA) for QC analysis using Bioanalyzer
High Sensitivity chip (Agilent). To accurately quantify the library
concentration for the cluster generation, the library was mea-
sured by qPCR using NEBNext Library Quant Kit (New England
BioLabs) using QuantStudio 5 Real-Time PCR Systems (Thermo
Fisher). Next, individually indexed and compatible libraries
were proportionally pooled (25 million reads per sample in
general) for clustering in cBot system (Illumina, San Diego, CA).
Libraries at the final concentration of 15 pM were clustered onto
a single read (SR) flow cell using Illumina TruSeq SR Cluster kit
v3, and sequenced to 51 bp using TruSeq SBS kit on Illumina
HiSeq system. All fastq files were adapter trimmed prior to
alignment. Files were aligned against Human (GRch37/
Ensembl). Sequence alignment was performed using Bowtie2
and RSEM [76]. Post-alignment, raw read counts were extracted
and normalized to account for difference in read depth using
DESeq [77]. Following normalization, gene read counts were fil-
tered to remove low read values: maximum Reads Per Kilobase
of transcript, per Million mapped reads (RPKM) across all sam-
ples must be  1. Differentially expressed (DE) genes were iden-
tified using DESeq, and genes with an FDR adjusted P-value
(q-value) < 0.1 and fold of change 1.2, were considered
significant.
Ingenuity Pathway Analysis
To better understand the biological meaning of the methylation
changes, genes associated with identified differentially methyl-
ated CpG sites were extracted from the EPIC array annotation
file and imported into Ingenuity Pathway Analysis (IPA,
Ingenuity Systems, Redwood City, CA) for pathway mapping
(canonical pathways). A cutoff of 0.05 was used for statistical
significance in IPA analysis.
Bisulfite Pyrosequencing and Oxidative Bisulfite
Pyrosequencing
A total of 200 ng genomic DNA was subjected to paired sodium
bisulfite treatment and oxidative sodium bisulfite treatment.
The TrueMethylVR protocol for array analysis (CEGXTM) was used
according to the manufacturer’s specifications. Standard PCR
amplification reactions were performed to amplify targeted
gene fragments at an annealing temperature of 50C before be-
ing subjected to pyrosequencing. The generated pyrograms
were automatically analysed using PyroMark analysis software
(Qiagen, Valencia, CA, USA). Pyrosequencing assay design
and genomic coordinates are documented in Supplementary
Table S1.
Quantitative RT-qPCR
Total RNA was reverse-transcribed to cDNA using the VILO
cDNA kit (Thermo Fisher Scientific, Waltham, MA, USA) accord-
ing to the manufacturer’s instructions. Real-time quantitative
PCR was performed using the SYBR Green Master Kit and
LightCyclerVR 480 instrument (Roche Diagnostics, Indianapolis,
IN, USA). PCR was carried out in triplicate for each cDNA and
the mean Ct value of the triplicate reaction was normalized
against the mean Ct value of GAPDH. For the time course experi-
ment, normalized values (to GAPDH) from treated samples at
each time point were also normalized to their respective con-
trols (values set to be 1) and resulting values were plotted.
Primer sequences are provided in Supplementary Table S2.
Functional Genomics Analyses
To identify transcription factors (TFs) and other epigenetic
marks that might be enriched at 5hmC and 5mC sites, we used
a computational method that overlaps a set of genomic loca-
tions (e.g. regions with 5hmC marks) with a large collection of
functional genomics datasets. To this end, we created a library
of 1544 TF ChIP-seq datasets by compiling data from a variety of
sources, including ENCODE [78], Cistrome [79], PAZAR [80] and
Re-Map [81]. The library consists of ChIP-seq peaks monitoring
the binding interactions of 390 different proteins in 487 cell lines
and tissue types. We also created an analogous library
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consisting of 1207 epigenetic data sets (ChIP-seq for histone
marks, DNase-seq, ATAC-seq, etc), from sources such as
ENCODE, Roadmap Epigenomics [82], and a study performing
ChIP-seq in many EBV-infected B cell lines [83]. In total, this li-
brary consists of ChIP-seq peaks monitoring the presence of 31
different histone marks in 204 cell lines and tissue types.
As input, the method takes a set of genomic loci (e.g. regions
with differential 5hmC marks). The coordinates of each locus
are padded by 100 bases in either direction (to account for ex-
perimental resolution). The resulting loci are then systemati-
cally intersected with the ChIP-seq and epigenetic data set
libraries, and the number of input regions overlapping each
dataset by at least one base is counted. Next, a P-value describ-
ing the significance of this overlap is estimated using a
simulation-based procedure. To this end, a ‘negative set’ is cre-
ated for comparison to the input set, which contain regions
with 5mC and 5hmC marks (beta0.1) but no significant differ-
ences between control and treated cell lines (absolute paired
difference< 0.1). A distribution of expected overlap values is
then created from 1000 iterations of randomly sampling from
the negative set, each time choosing a set of negative examples
that match the input set in terms of the total number of geno-
mic loci and the length of each locus. The distribution of the
expected overlap values from the randomized data resembles a
normal distribution, and can thus be used to generate a Z-score
and corresponding P-value estimating the significance of the
observed number of input regions that overlap each data set.
Collectively, this procedure controls for the count and sizes of
the input loci, and the count and sizes of each individual data-
set in the library.
We also examined genomic loci with 5hmC and 5mC marks
using standard TF motif enrichment analysis. To this end, we
used the HOMER motif enrichment algorithm [84] and a large li-
brary of human position weight matrix (PWM) binding site mod-
els obtained from the CisBP database [85]. For each analysis, we
used the aforementioned negative set to provide background
sequences to HOMER.
Statistical Analysis
Expression in HBEC between control and DEP/HDM treated or
TET1 knockdown groups were compared by two-sided t-tests in
GraphPad Prism (CA, USA). A P value 0.05 was used to indicate
statistical significance.
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